Carlyle Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Carlyle Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.78B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.43B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.96B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $8.78B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $1.51B | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | $1.03B | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | $1.13B | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | ($745.70M) | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $460.30M | Feb 11, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $808.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.02B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($608.40M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.23B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.97B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $348.20M | May 4, 2023 |
| FY2019 | Dec 31, 2019 | ($8.30M) | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | $68.40M | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | $148.20M | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | $137.00M | Feb 12, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.28B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($759.50M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $204.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($379.30M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.79B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | ($169.20M) | May 4, 2023 |
| FY2021 | Dec 31, 2019 | $358.60M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | ($343.50M) | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | ($7.10M) | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | ($300.60M) | Feb 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.40M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $77.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $66.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $40.60M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $41.40M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $61.20M | May 4, 2023 |
| FY2021 | Dec 31, 2019 | $27.80M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $31.30M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $34.00M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $25.40M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.12B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $23.10B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $21.18B | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | $21.40B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $21.25B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $15.64B | May 4, 2023 |
| FY2021 | Dec 31, 2019 | $13.81B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $12.91B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $12.28B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $9.97B | Feb 13, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.06B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $16.76B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $15.39B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $14.58B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $15.54B | May 4, 2023 |
| FY2021 | Dec 31, 2020 | $12.71B | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $10.84B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $10.08B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $9.33B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $8.52B | Feb 15, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $103.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $104.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $103.90M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $13.30M | May 4, 2023 |
| FY2021 | Dec 31, 2020 | $16.80M | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $16.10M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $15.30M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $11.10M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $10.10M | Feb 15, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.04B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.08B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.40B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.81B | May 4, 2023 |
| FY2021 | Dec 31, 2020 | $348.20M | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Feb 11, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.27B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.44B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.36B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.47B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $987.60M | May 4, 2023 |
| FY2021 | Dec 31, 2019 | $793.40M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $629.60M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.00B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $670.90M | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $144.40M | Feb 16, 2017 |
| FY2015 | Dec 31, 2015 | $125.60M | Feb 24, 2016 |
| FY2014 | Dec 31, 2014 | $243.60M | Feb 26, 2015 |
| FY2013 | Dec 31, 2013 | $305.30M | Feb 27, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | (1) | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | (1) | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 357.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 357.18M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 361.33M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 362.30M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 355.37M | May 4, 2023 |
| FY2021 | Dec 31, 2020 | 353.52M | Feb 10, 2022 |
| FY2019 | Dec 31, 2019 | 117.84M | Feb 12, 2020 |
| FY2019 | Dec 31, 2018 | 107.75M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | 100.10M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 84.61M | Feb 15, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $505.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $503.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $497.70M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $443.60M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $355.80M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $351.30M | May 4, 2023 |
| FY2021 | Dec 31, 2019 | $154.90M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $129.80M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $118.10M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $140.90M | Feb 13, 2019 |